Skip to content
Independent analysis of NHS open data
PharmaInsight

Doravirine/lamivudine/tenofovir disoproxil

Infections Antiviral drugs BNF 0503010AS
Data updated March 2026 Download CSV
1items

Dispensed in March 2026

2items

Rolling 12 months

£579

Net ingredient cost · March 2026

Figure 1. Doravirine/lamivudine/tenofovir disoproxil: national items dispensed by month

0 1 2 May 2021 Dec 2021 Aug 2022 Jan 2024 Apr 2024 Apr 2025 Mar 2026 1 May 2021: 2 Sep 2021: 1 Dec 2021: 1 Jan 2022: 2 Aug 2022: 2 Oct 2022: 2 Jan 2024: 1 Mar 2024: 1 Apr 2024: 1 Aug 2024: 1 Apr 2025: 1 May 2025: 1 Oct 2025: 1 Mar 2026: 1

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV
Embed this chart

At a glance

  • Therapeutic class Antiviral drugs
  • Presentations 1 shown
  • Average cost / item £578.55
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, March 2026

The individual products dispensed under Doravirine/lamivudine/tenofovir disoproxil this month.

Presentations of Doravirine/lamivudine/tenofovir disoproxil, March 2026
Presentation BNF code Items Net ingredient cost
Delstrigo 100mg/300mg/245mg tablets 0503010ASBBAAAA 1 £579

Source: NHSBSA Prescription Cost Analysis · to March 2026 OGL v3.0

Where Doravirine/lamivudine/tenofovir disoproxil is dispensed

The regions and dispensing practices with the highest Doravirine/lamivudine/tenofovir disoproxil volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Doravirine/lamivudine/tenofovir disoproxil with

Other medicines in the same BNF section, by prescribing volume.